• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Hiramatsu Hiroaki  平松 寛明

ORCIDConnect your ORCID iD *help
Researcher Number 70827253
Other IDs
Affiliation (based on the past Project Information) *help 2019 – 2023: 名古屋大学, 医学系研究科, 研究員
Review Section/Research Field
Principal Investigator
Basic Section 50020:Tumor diagnostics and therapeutics-related
Except Principal Investigator
Basic Section 50020:Tumor diagnostics and therapeutics-related / Medium-sized Section 90:Biomedical engineering and related fields
Keywords
Principal Investigator
T細胞リンパ腫 / 抗体医薬 / ケモカイン受容体 / モガムリズマブ / CCR4 / ATLL / 腫瘍免疫 / タンパク質間相互作用 / クロマチン免疫沈降法 / エンハンサー … More / プロモーター / sgRNA / 転写因子複合体 / 共免疫沈降法 / dCas9 / 部位特異的ChIP法 … More
Except Principal Investigator
IgG / CCR4 / 成熟T細胞腫瘍 / B細胞受容体 / クラススイッチ / 体細胞超変異 / 免疫グロブリン / ATL / Somatic Hyper Mutation / TGF-beta / 人工キメラ受容体 / 遺伝子改変T細胞療法 / TGF-β受容体 / TGF-β / CAR-T Less
  • Research Projects

    (4 results)
  • Research Products

    (1 results)
  • Co-Researchers

    (3 People)
  •  Landscape of humoral immune system in patients with mature T-cell neoplasms, and its clinical application

    • Principal Investigator
      石田 高司
    • Project Period (FY)
      2022 – 2024
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Review Section
      Basic Section 50020:Tumor diagnostics and therapeutics-related
    • Research Institution
      Nagoya University
  •  Establishment of the gene engineering T cell therapy enhancing the migration activity to cancer

    • Principal Investigator
      Ishida Takashi
    • Project Period (FY)
      2021 – 2023
    • Research Category
      Grant-in-Aid for Challenging Research (Exploratory)
    • Review Section
      Medium-sized Section 90:Biomedical engineering and related fields
    • Research Institution
      Nagoya University
  •  Innovations in anti-CCR4 antibody therapy based on elucidation of molecular dynamics of CCR4 mutantsPrincipal Investigator

    • Principal Investigator
      Hiramatsu Hiroaki
    • Project Period (FY)
      2021 – 2023
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 50020:Tumor diagnostics and therapeutics-related
    • Research Institution
      Nagoya University
  •  Study of regulatory mechanisms of gene expression that determine immunosuppressive potential for application to cancer immunotherapyPrincipal Investigator

    • Principal Investigator
      Hiramatsu Hiroaki
    • Project Period (FY)
      2019 – 2021
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 50020:Tumor diagnostics and therapeutics-related
    • Research Institution
      Nagoya University

All 2023

All Journal Article

  • [Journal Article] Clinical landscape of TP73 structural variants in ATL patients2023

    • Author(s)
      Hiramatsu Hiroaki、Yokomori Rui、Shengyi Liu、Tanaka Norio、Mori Seiichi、Kiyotani Kazuma、...., Imaizumi Yoshitaka、Iida Shinsuke、Utsunomiya Atae、Noda Tetsuo、Nishikawa Hiroyoshi、Ueda Ryuzo、Sanda Takaomi、Ishida Takashi
    • Journal Title

      Leukemia

      Volume: 37 Issue: 12 Pages: 2502-2506

    • DOI

      10.1038/s41375-023-02059-9

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18K19960, KAKENHI-PROJECT-21K19900, KAKENHI-PROJECT-22H00455, KAKENHI-PROJECT-21H02793, KAKENHI-PROJECT-23K24179, KAKENHI-PROJECT-23K27469
  • 1.  Ishida Takashi (80405183)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 0 results
  • 2.  三田 貴臣
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 3.  飯田 真介
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi